Page last updated: 2024-10-23

aztreonam and Kidney, Polycystic

aztreonam has been researched along with Kidney, Polycystic in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mojica, MF1
Ouellette, CP1
Leber, A1
Becknell, MB1
Ardura, MI1
Perez, F1
Shimamura, M1
Bonomo, RA1
Aitken, SL1
Shelburne, SA1

Other Studies

1 other study available for aztreonam and Kidney, Polycystic

ArticleYear
Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamases; Ceftazidime; Co

2016